Use of mysoline in barbiturate withdrawal.
D000927:Anticonvulsants / Q000627:therapeutic use*; D001463:Barbiturates / Q000009:adverse effects*; D016739:Behavior, Addictive; D006801:Humans; D011324:Primidone; D011605:Psychoses, Substance-Induced; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders
D000927:Anticonvulsants; D001463:Barbiturates; D011324:Primidone; C032232:barbituric acid
ANTICONVULSANTS/therapeutic use; BARBITURATES/addiction